Merck’s Oral Antiviral Data In COVID-19 May Change Pandemic Outlook

 
• By Joseph Haas
Coronavirus with cardio lines, cellular designs and lungs
Oral antiviral shows ability to reduce risk of COVID-19 hospitalization and death

More from COVID-19

More from Scrip